Article
ErbB and Nrg
1 Jan 2008
Abstract excerpt
OBJECTIVE: Identify molecular targets for development of tumor-specific pharmacotherapeutics aimed at treating vestibular schwannomas (VSs). Activated epidermal growth factor receptor B (ErbB) 2 and ErbB3 are abundantly expressed in VS. ErbB2 signaling is essential for Schwann cell differentiation, survival, and proliferation. VS arise after loss of functional merlin, a putative tumor suppressor. Merlin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
